Place of bupropion in smoking-cessation therapy

Lancet

Volumn 357, Issue 9268, 2001, Pages 1550-

  Silagy, C ^a   Formica, N ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DOPAMINE; FLUOXETINE; NICOTINE; NORADRENALIN; NORTRIPTYLINE;

CIGARETTE SMOKING; DRUG EFFICACY; HUMAN; INSOMNIA; NOTE; PRIORITY JOURNAL; SEIZURE; SMOKING CESSATION; SUBSTITUTION THERAPY; TOBACCO DEPENDENCE;

EID: 0035912559     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04781-4     Document Type: Note

References (6)

1. R Peto AD Lopez The future of worldwide smoking patterns CE Koop C Pearson RM Schwarz Critical issues in global health 2000 Jossey-Bass New York 154 161
2. T Lancaster L Stead C Silagy A Sowden Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library BMJ 321 2000 355 358
3. DE Jorenby SJ Leischow MA Nides A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N Engl J Med 340 1999 685 691
4. JR Hughes LF Stead T Lancaster Anxiolytics and antidepressants for smoking cessation (Cochrane Review) Cochrane Database Syst Rev 2 2000 CD000031
5. MC Fiore WC Bailey SJ Cohen Treating tobacco use and dependence Quick reference guide for clinicians October, 2000 US Department of Health and Human Services Rockville, MD Public Health Service
6. R West A McNeill M Raw Smoking-cessation guidelines for health professionals: an update Thorax 55 2000 987 999